Skip to main content

Inside the growing treatment market for rare diseases

Amid the flurry of deals and growing interest in the space, approvals for new rare disease drugs have skyrocketed. Even with smaller patient populations, high-tech treatments for rare diseases — such as cell and gene therapies — have proven lucrative.

included in this trendline
  • A rare disease researcher aims to tackle disability discrimination in new lawsuit
  • A drug just launched for a disease discovered only 10 years ago
  • Janssen neuroscience leader takes on rare diseases one small ‘eureka’ at a time
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.